Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

The prevention of cardiovascular disease in cancer survivors.

Daher IN, Daigle TR, Bhatia N, Durand JB.

Tex Heart Inst J. 2012;39(2):190-8.

2.

Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD.

J Clin Oncol. 2010 Oct 20;28(30):4649-57. doi: 10.1200/JCO.2010.29.9362. Epub 2010 Sep 20.

PMID:
20855830
3.

Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.

Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, Plana JC, Soliman EZ, Green DM, Srivastava D, Santucci A, Krasin MJ, Robison LL, Hudson MM.

Ann Intern Med. 2016 Jan 19;164(2):93-101. doi: 10.7326/M15-0424. Epub 2016 Jan 5.

4.

High risk of symptomatic cardiac events in childhood cancer survivors.

van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, Sieswerda E, Oldenburger F, Koning CC, van Leeuwen FE, Caron HN, Kremer LC.

J Clin Oncol. 2012 May 1;30(13):1429-37. doi: 10.1200/JCO.2010.33.4730. Epub 2012 Apr 2.

PMID:
22473161
5.

Late somatic sequelae after treatment of childhood cancer in Slovenia.

Erman N, Todorovski L, Jereb B.

BMC Res Notes. 2012 May 24;5:254. doi: 10.1186/1756-0500-5-254.

6.

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.

Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ; ASCO Cancer Survivorship Expert Panel.

J Clin Oncol. 2007 Sep 1;25(25):3991-4008. Epub 2007 Jun 18. Review.

PMID:
17577017
7.

Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors.

Knijnenburg SL, Jaspers MW, van der Pal HJ, Schouten-van Meeteren AY, Bouts AH, Lieverst JA, Bökenkamp A, Koning CC, Oldenburger F, Wilde JC, van Leeuwen FE, Caron HN, Kremer LC.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1416-27. Epub 2012 Jul 19.

8.

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.

Knijnenburg SL, Mulder RL, Schouten-Van Meeteren AY, Bökenkamp A, Blufpand H, van Dulmen-den Broeder E, Veening MA, Kremer LC, Jaspers MW.

Cochrane Database Syst Rev. 2013 Oct 8;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2. Review.

PMID:
24101439
9.

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Petersen EJ, Raemaekers JM, Kok WE, Aleman BM, van Leeuwen FE.

JAMA Intern Med. 2015 Jun;175(6):1007-17. doi: 10.1001/jamainternmed.2015.1180.

PMID:
25915855
10.

Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009.

Underwood JM, Townsend JS, Stewart SL, Buchannan N, Ekwueme DU, Hawkins NA, Li J, Peaker B, Pollack LA, Richards TB, Rim SH, Rohan EA, Sabatino SA, Smith JL, Tai E, Townsend GA, White A, Fairley TL; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2012 Jan 20;61(1):1-23.

11.

Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.

Dillenburg RF, Nathan P, Mertens L.

Eur J Pediatr. 2013 Sep;172(9):1149-60. doi: 10.1007/s00431-013-1931-9. Epub 2013 Jan 30. Review.

PMID:
23361962
12.

Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry.

Felicetti F, D'Ascenzo F, Moretti C, Corrias A, Omedè P, Marra WG, Arvat E, Fagioli F, Brignardello E, Gaita F.

Eur J Prev Cardiol. 2015 Jun;22(6):762-70. doi: 10.1177/2047487314529348. Epub 2014 Apr 1.

PMID:
24691151
13.

Vascular injury in cancer survivors.

Mulrooney DA, Blaes AH, Duprez D.

J Cardiovasc Transl Res. 2012 Jun;5(3):287-95. doi: 10.1007/s12265-012-9358-7. Epub 2012 Mar 29.

PMID:
22456863
14.

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.

Adams MJ, Lipshultz SE.

Pediatr Blood Cancer. 2005 Jun 15;44(7):600-6. Review.

PMID:
15856486
15.

Endothelial damage in long-term survivors of childhood cancer.

Brouwer CA, Postma A, Hooimeijer HL, Smit AJ, Vonk JM, van Roon AM, van den Berg MP, Dolsma WV, Lefrandt JD, Bink-Boelkens MT, Zwart N, de Vries EG, Tissing WJ, Gietema JA.

J Clin Oncol. 2013 Nov 1;31(31):3906-13. doi: 10.1200/JCO.2012.46.6086. Epub 2013 Sep 23.

PMID:
24062395
16.

Physical performance limitations in the Childhood Cancer Survivor Study cohort.

Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, Whitton J, Robison LL, Gurney JG.

J Clin Oncol. 2009 May 10;27(14):2382-9. doi: 10.1200/JCO.2008.21.1482. Epub 2009 Mar 30. Review.

17.

Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer.

Berkman AM, Lakoski SG.

J Am Heart Assoc. 2015 Apr 2;4(4). pii: e001891. doi: 10.1161/JAHA.115.001891. Review. No abstract available.

18.

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC.

J Clin Oncol. 2009 May 10;27(14):2328-38. doi: 10.1200/JCO.2008.21.1425. Epub 2009 Mar 30. Review.

19.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

20.

Predicting and preventing the cardiotoxicity of cancer therapy.

Anderson B, Sawyer DB.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):1023-33. doi: 10.1586/14779072.6.7.1023. Review.

PMID:
18666852

Supplemental Content

Support Center